Search research articles
Contact Us
Filters
Showing results (101-110 of 118) with videos related to
Page
of 12
Sort By:
European Journal of Clinical Pharmacology
|
June 17, 1998
Drug utilization 90%--a simple method for assessing the quality of drug prescribing
U Bergman, C Popa, Y Tomson, et al.
European Journal of Respiratory Diseases
|
May 1, 1982
Theophyllines three times daily - when are the doses actually taken? - Pharmacokinetic ideals versus clinical practice
L Alfredsson, U Bergman, R Eriksson, et al.
British Journal of Clinical Pharmacology
|
April 24, 1999
Low use of long-term hormone replacement therapy in Denmark
C Olesen, F H Steffensen, H T Sørensen, et al.
Clinical Pharmacology and Therapeutics
|
August 1, 1990
Benefits, risks, and costs of prescription drugs: a scientific basis for evaluating policy options
G M Anderson, W O Spitzer, M C Weinstein, et al.
American Journal of Obstetrics and Gynecology
|
October 10, 1997
Modern oral contraceptives and cardiovascular disease
L Rosenberg, J R Palmer, M I Sands, et al.
Journal of Clinical Epidemiology
|
January 1, 1988
Fatal upper gastrointestinal hemorrhage or perforation among users and nonusers of nonsteroidal anti-inflammatory drugs in Saskatchewan, Canada 1983
H A Guess, R West, L M Strand, et al.
Journal of Population Therapeutics and Clinical Pharmacology = Journal De La Therapeutique Des Populations Et De La Pharmacologie Clinique
|
May 3, 2012
Prescribing indicators: what can Canada learn from European countries?
I S Sketris, J E Fisher, E M Langille Ingram, et al.
Lakartidningen
|
March 29, 2001
[Feedback on prescribing profiles at a primary health center. Important element in quality assurance of drug prescription]
K Nyman, A Bergens, A S Björin, et al.
American Journal of Hospital Pharmacy
|
June 1, 1984
Spacing of medications scheduled t.i.d
S E Norell, L Alfredsson, U Bergman, et al.
European Journal of Clinical Pharmacology
|
January 1, 1985
Validation of observed differences in the utilization of antihypertensive and antidiabetic drugs in Northern Ireland, Norway and Sweden
K Griffiths, D G McDevitt, M Andrew, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 118) with videos related to
Sort By:
Page
of 12
European Journal of Clinical Pharmacology
|
June 17, 1998
Drug utilization 90%--a simple method for assessing the quality of drug prescribing
U Bergman, C Popa, Y Tomson, et al.
European Journal of Respiratory Diseases
|
May 1, 1982
Theophyllines three times daily - when are the doses actually taken? - Pharmacokinetic ideals versus clinical practice
L Alfredsson, U Bergman, R Eriksson, et al.
British Journal of Clinical Pharmacology
|
April 24, 1999
Low use of long-term hormone replacement therapy in Denmark
C Olesen, F H Steffensen, H T Sørensen, et al.
Clinical Pharmacology and Therapeutics
|
August 1, 1990
Benefits, risks, and costs of prescription drugs: a scientific basis for evaluating policy options
G M Anderson, W O Spitzer, M C Weinstein, et al.
American Journal of Obstetrics and Gynecology
|
October 10, 1997
Modern oral contraceptives and cardiovascular disease
L Rosenberg, J R Palmer, M I Sands, et al.
Journal of Clinical Epidemiology
|
January 1, 1988
Fatal upper gastrointestinal hemorrhage or perforation among users and nonusers of nonsteroidal anti-inflammatory drugs in Saskatchewan, Canada 1983
H A Guess, R West, L M Strand, et al.
Journal of Population Therapeutics and Clinical Pharmacology = Journal De La Therapeutique Des Populations Et De La Pharmacologie Clinique
|
May 3, 2012
Prescribing indicators: what can Canada learn from European countries?
I S Sketris, J E Fisher, E M Langille Ingram, et al.
Lakartidningen
|
March 29, 2001
[Feedback on prescribing profiles at a primary health center. Important element in quality assurance of drug prescription]
K Nyman, A Bergens, A S Björin, et al.
American Journal of Hospital Pharmacy
|
June 1, 1984
Spacing of medications scheduled t.i.d
S E Norell, L Alfredsson, U Bergman, et al.
European Journal of Clinical Pharmacology
|
January 1, 1985
Validation of observed differences in the utilization of antihypertensive and antidiabetic drugs in Northern Ireland, Norway and Sweden
K Griffiths, D G McDevitt, M Andrew, et al.
Page
of 12